Free tool
Healthcare stocks
We cover 81 companies in the Healthcare sector. The median market value in the group is $778.90M. Across the group, the median move over the past trading day is +0.25%. 98% of the 80 with a 200-day average trade above it. Price change over the past year runs from −24.9% to +292.4% across the middle 80 percent of the group, with a median of +58.4%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
81 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% | Nov 5, 2026 |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% | Nov 5, 2026 |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% | Nov 4, 2026 |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% | Nov 11, 2026 |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% | Nov 5, 2026 |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% | Nov 11, 2026 |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% | Oct 29, 2026 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% | Nov 5, 2026 |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% | Nov 9, 2026 |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% | Nov 5, 2026 |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% | Nov 9, 2026 |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% | Nov 5, 2026 |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% | Nov 5, 2026 |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% | Nov 5, 2026 |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% | Nov 12, 2026 |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% | Nov 3, 2026 |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% | Nov 13, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% | Nov 5, 2026 |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% | Nov 13, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% | Nov 4, 2026 |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% | Nov 5, 2026 |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% | Nov 4, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% | Nov 4, 2026 |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% | Nov 5, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% | Nov 13, 2026 |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% | Nov 12, 2026 |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% | Nov 9, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% | Nov 5, 2026 |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% | Nov 4, 2026 |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% | Nov 11, 2026 |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% | Nov 12, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% | Nov 5, 2026 |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% | Nov 5, 2026 |
| 6523.T | PHC Holdings Corporation | $1.21B | Small cap | +58.42% | Nov 11, 2026 |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% | Nov 5, 2026 |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% | Nov 12, 2026 |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% | Nov 5, 2026 |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% | Nov 17, 2026 |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% | Nov 3, 2026 |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% | Nov 4, 2026 |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% | Nov 4, 2026 |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% | Nov 12, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% | Nov 11, 2026 |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% | Oct 23, 2026 |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% | Sep 8, 2026 |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% | Nov 4, 2026 |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% | Nov 5, 2026 |
| ARCT | Arcturus Therapeutics Holdings Inc. | $449.94M | Small cap | −8.44% | Nov 9, 2026 |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% | Nov 5, 2026 |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% | Nov 6, 2026 |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% | Aug 31, 2026 |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% | Oct 22, 2026 |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% | Nov 5, 2026 |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% | Nov 11, 2026 |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% | Nov 3, 2026 |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% | Nov 12, 2026 |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% | Aug 28, 2026 |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% | Sep 29, 2026 |
| ACB | Aurora Cannabis Inc. | $253.24M | Small cap | −24.95% | Nov 4, 2026 |
| ACB.TO | Aurora Cannabis Inc. | $252.71M | Small cap | −24.93% | Nov 4, 2026 |
| CRDL | Cardiol Therapeutics Inc. | $250.00M | Small cap | +91.07% | Nov 12, 2026 |
| CRDL.TO | Cardiol Therapeutics Inc. | $249.99M | Small cap | +90.38% | Nov 12, 2026 |
| XLY.TO | Auxly Cannabis Group Inc. | $232.81M | Small cap | +1919.35% | Nov 12, 2026 |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% | Nov 23, 2026 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.56M | Small cap | +7.93% | Nov 16, 2026 |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% | Nov 12, 2026 |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% | Nov 10, 2026 |
| BICO.ST | BICO Group AB (publ) | $147.45M | Small cap | −17.00% | Nov 11, 2026 |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% | Nov 3, 2026 |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% | Nov 3, 2026 |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% | Nov 11, 2026 |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% | Oct 29, 2026 |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% | Oct 30, 2026 |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% | Nov 5, 2026 |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% | Nov 9, 2026 |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% | Nov 11, 2026 |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% | Nov 12, 2026 |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% | Nov 9, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.